Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients
Sponsor: CordCell
Listed as NCT02412332, this PHASE1/PHASE2 trial focuses on Chronic Obstructive Pulmonary Disease (COPD) and remains ongoing. Sponsored by CordCell, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE1_PHASE2
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CordCell
- Faculdade de Medicina do ABC
- Hemocentro São Lucas
- IEP São Lucas - Instituto de Ensino e Pesquisa
- UPECLIN HC FM Botucatu Unesp
For direct contact, visit the study record on ClinicalTrials.gov .